Search Login Register
Necrobiotic Xanthogranuloma
Summary
Description:
A cutaneous necrobiotic disorder characterized by firm, yellow plaques or nodules, often in a periorbital distribution. It is often accompanied by an elevated ERYTHROCYTE SEDIMENTATION RATE; LEUKOPENIA; and MONOCLONAL GAMMOPATHY (IgG-kappa type) and systemic involvement.
Also Known As:
Necrobiotic Xanthogranulomas; Xanthogranuloma, Necrobiotic; Xanthogranulomas, Necrobiotic
Networked: 63
relevant articles (3 outcomes,
2 trials/studies)
for this Disease
Key Drugs and Agents for Necrobiotic Xanthogranuloma
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Prednisolone (Predate)
:
1 outcome in 4 results
:
FDA 55
Generic
-
Melphalan (Alkeran)
:
1 outcome in 4 results
:
FDA 2
Generic
-
Interferons
:
1 outcome in 2 results
: IBA
-
Ficusin (Psoralen)
:
1 outcome in 1 result
: IBA
-
Immunoglobulin G (IgG)
:
1 study in 12 results
: IBA
-
Immunoglobulins (Immunoglobulin)
:
1 study in 5 results
: IBA
-
Dexamethasone (Maxidex)
:
5 results
:
FDA 77
Generic
-
Immunoglobulin A (IgA)
:
4 results
: IBA
-
Cholesterol
:
4 results
: IBA
-
Chlorambucil (Leukeran)
:
4 results
:
FDA 1
Show All >>
Diseases Related to Necrobiotic Xanthogranuloma
-
Neurologic Manifestations (Neurological Manifestations)
-
Paraproteinemias (Monoclonal Gammopathy)
-
Necrobiosis Lipoidica
-
Multiple Myeloma
-
Granuloma
Show All >>
Key Therapies for Necrobiotic Xanthogranuloma
Efficacy Chart >>
-
Plasmapheresis
:
1 outcome in 2 results
-
Drug Therapy (Chemotherapy)
:
1 outcome in 1 result
-
Stem Cell Transplantation
:
1 result
-
Blepharoplasty
:
1 result
-
Transplants (Transplant)
:
1 result
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.